Clinical Trials Directory

Trials / Unknown

UnknownNCT04930458

Remineralization of Dentine Caries Using Two Remineralizing Agents Which Are Nanosilver Fluoride and Casein phosphopeptides_amorphous Calcium Phosphate

Remineralization of Dentine Caries Using Nanosilver Fluoride and Casein Phosphopeptides-amorphous Calcium Phosphate (A Randomized Clinical Trial)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
135 (estimated)
Sponsor
University of Baghdad · Academic / Other
Sex
All
Age
6 Years – 12 Years
Healthy volunteers
Accepted

Summary

The study is randomized controlled trial ...The null hypothesis suggests that there is no significant difference between nanosilver fluoride and sodium fluoride with Casein phosphopeptides\_amorphous calcium phosphate in the remineralization of dental caries.

Detailed description

the patients will be randomly assigned to one of three study groups the first group is nanosilver fluoride,the second is casein phosphopeptides\_amorphous calcium phosphate and the third is sodium fluoride as positive control..the three material will be applied in single application with no repetition ..follow up after one and three month ..the patient should have at least one carious lesion(ICDASII code 5)

Conditions

Interventions

TypeNameDescription
OTHERNanosilver fluorideNanosilver fluoride will be applied to the affected tooth in single application and then follow up after one and three months
OTHERSodium fluoride with casein phosphopeptides amorphous calcium phosphateSodium fluoride with casein phosphopeptides amorphous calcium phosphatewill be applied to the affected tooth in single application and then follow up after one and three months
OTHERSodium fluoride varnishSodium fluoride varnish will be applied to the affected tooth in single application and then follow up after one and three months

Timeline

Start date
2021-08-10
Primary completion
2021-09-20
Completion
2022-06-20
First posted
2021-06-18
Last updated
2022-05-17

Locations

1 site across 1 country: Iraq

Source: ClinicalTrials.gov record NCT04930458. Inclusion in this directory is not an endorsement.